湖北兴发化工集团股份有限公司 2024 年度股东会 会 议 材 料 湖北兴发化工集团股份有限公司董事会 二O二五年四月十六日 会议议程 会议时间：2025 年 4 月 24 日（星期四）14:00 会议地点：湖北省宜昌市伍家岗区沿江大道 188-9 号兴发大厦会议室 会议议程： 一、主持人宣布本次股东会开始，宣布出席会议股东、董事、 监事、高管以及见证律师情况 - 1 - 二、推选计票人和监票人 三、介绍人宣读议案 四、股东讨论并审议议案 五、股东进行书面投票表决 六、统计现场投票表决情况 七、宣布现场投票表决结果 八、由见证律师宣读为本次股东会出具的法律意见书 九、签署会议文件 十、主持人宣布本次股东会结束 会议须知 为维护股东的合法权益，确保兴发集团2024年度股东会的正常 秩序和议事效率，根据《公司法》《公司章程》和《股东会议事规 则》的有关规定，现就会议须知通知如下，望参加本次会议的全体 人员遵守。 一、本次会议期间，全体参会人员应以维护股东的合法权益， 确保会议的正常秩序和议事效率为原则，自觉履行法定义务。 二、为保证本次会议的严肃性和正常秩序，除出席会议的股东 及股东代理人、董事、监事、董事会秘书 ...

证券代码：600141 证券简称：兴发集团 公告编号：临2025-023 转债代码：110089 转债简称：兴发转债 湖北兴发化工集团股份有限公司 关于不向下修正"兴发转债"转股价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ●自2025 年3 月22 日起至2025 年4 月14 日，湖北兴发化工集团股份有 限公司（以下简称"公司"）股票在连续30 个交易日中已有15 个交易日的收 盘价低于当期转股价格的85%（24.99 元/股），已触发"兴发转债"转股价格 向下修正条款。 ●经公司第十一届董事会第八次会议审议通过，公司董事会决定本次暂不 行使"兴发转债"转股价格向下修正的权利。同时，自本次董事会审议通过的 次一交易日起未来十二个月内（即 2025 年 4 月 15 日至 2026 年 4 月 14 日）， 如再次触发"兴发转债"转股价格向下修正条款，公司亦不提出向下修正方案； 自2026 年4 月15 日起，如再次触发"兴发转债"转股价格向下修正条款，届 时公司董事会将再次召开会议决定是 ...

点评： 事件：兴发集团2024 年实现营业收入283.96 亿元，同比增长0.41%；实现归母净利润16.01 亿元，同比 增长14.33%。公司拟每10 股派现10元（含税）。 磷矿石高景气带动公司业绩稳中向好。2024 年，兴发集团实现营业收入283.96 亿元，同比微增0.41%； 归母净利润16.01 亿元，同比增长14.33%。其中，第四季度营收为63.46 亿元，同比增长1.70%，环比下 降26.60%，归母净利润2.87 亿元，同比下降35.82%，环比下降43.63%。磷矿业务大幅增长成为稳定公 司业绩的主要因素。受益于磷矿石价格高位运行（湖北30%品位船板价近三年稳定于900 元/吨以上）， 公司矿山采选2024 年营收35.57 亿元，同比增长65.28%，毛利率74.28%（同比+5.40pcts）。特种化学品 业务稳中有进，在电子化学品、高端新材料等领域取得技术突破，电子级磷酸、硫酸等产品已达到国际 先进水平，供应国内外众多高端客户。2024 年公司特种化学品实现收入52.78 亿元，同比增长4.97%。 得益于磷矿石和特种化学品的带动，公司2024 年毛利率与净利率分别提升至19. ...

| 证券代码：600141 | 证券简称：兴发集团 | 公告编号：临2025-022 | | --- | --- | --- | | 转债代码：110089 | 转债简称：兴发转债 | | 湖北兴发化工集团股份有限公司 关于公司持股 5%以上股东增持进展暨权益变动触及 1%的 提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ●本次权益变动为湖北兴发化工集团股份有限公司（以下简称"公司"） 持股 5%以上股东浙江金帆达生化股份有限公司（以下简称"浙江金帆达"） 履行此前披露的增持股份计划所致，不触及要约收购。 ●本次权益变动不会导致公司控股股东及实际控制人发生变化。 ●浙江金帆达自 2025 年 1 月 23 日至 2025 年 4 月 9 日，通过上海证券交 易所系统以集中竞价交易方式累计增持公司股份 11,330,000 股，占公司总股 本的 1.03%。本次权益变动后，浙江金帆达持有公司股份数量由 162,397,372 股增加至 173,727,372 股，持股比例由 14.72%增加至 ...

[Table_MainInfo] 公司研究/化工/基础化工材料制品 证券研究报告 [Table_InvestInfo] [Table_Summary] 投资要点： 主要财务数据及预测 | [Table_FinanceInfo] 财务摘要（百万元） | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入 | 28,281 | 28,396 | 30,714 | 31,537 | 33,508 | | (+/-)% | -6.7% | 0.4% | 8.2% | 2.7% | 6.2% | | 净利润（归母） | 1,401 | 1,601 | 1,857 | 2,132 | 2,413 | | (+/-)% | -76.1% | 14.3% | 15.9% | 14.8% | 13.2% | | 每股净收益（元） | 1.27 | 1.45 | 1.68 | 1.93 | 2.19 | | 净资产收益率(%) | 6.7% | 7.5% | 8.4% | 9.2% | 10.0% | | 市盈率 ...

证券代码：600141 证券简称：兴发集团 公告编号：临 2025-021 转债代码：110089 转债简称：兴发转债 ●浙江金帆达生化股份有限公司（以下简称"浙江金帆达"）持有湖北兴 发化工集团股份有限公司（以下简称"公司"）股份173,036,872股，占公司 股份总数的15.68%。本次办理7,000,000股股份质押手续后，浙江金帆达持有 公司股份累计质押数量为63,000,000股，占其持有公司股份总数的比例为 36.41%。 近日，公司收到持股 5%以上股东浙江金帆达通知，浙江金帆达在中国证 券登记结算有限责任公司办理了股权质押登记手续。根据《上海证券交易所股 票上市规则》的相关规定，现将有关事宜公告如下： 湖北兴发化工集团股份有限公司 关于持股 5%以上股东股份质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 股东 名称 是否为 控股 股东 本次质押 股数（股） 是否为 限售股 是否补 充质押 质押 起始日 质押 到期日 质权人 占其所 持股份 比例（%） 占公司 总股份 比例（% ...

证券代码：600141 证券简称：兴发集团 公告编号：临2025-020 转债代码：110089 转债简称：兴发转债 湖北兴发化工集团股份有限公司 关于"兴发转债"预计满足转股价格修正条件的 提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ●证券代码：600141，证券简称：兴发集团 ●转债代码：110089，转债简称：兴发转债 ●转股价格：29.40 元/股 ●转股时间：2023 年3 月28 日至2028 年9 月21 日 ●自2025 年3 月22 日至2025 年4 月7 日，公司股票在连续30 个交易日 中已有10 个交易日的收盘价低于当期转股价格的85%（即24.99 元/股），预 计触发转股价格向下修正条件。若触发条件，公司将于触发条件当日召开董事 会审议决定是否修正转股价格，并及时履行信息披露义务。敬请广大投资者注 意投资风险。 一、可转债发行上市概况 （一）发行上市基本情况 根据中国证券监督管理委员会《关于核准湖北兴发化工集团股份有限公司 二、可转债转股价格修正条款与可能触发 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company's net profit increased year-on-year due to the recovery in the agricultural chemical market, with enhanced profitability in phosphate rock, phosphate fertilizer, and glyphosate products. However, Q4 performance was slightly below expectations due to a provision of approximately 355 million yuan [2] - The company has seen an increase in production and sales across its main products, with significant growth in special chemicals, glyphosate series, fertilizers, and organic silicon series. The company has also increased its cash dividend to 10 yuan per 10 shares (including tax), up from 6 yuan last year, resulting in a dividend yield of approximately 4.6% [3] - The company is investing 1.495 billion yuan to build a new 100,000 tons/year industrial silicon project, which will enhance its raw material supply for the organic silicon industry and improve operational efficiency [4] Summary by Sections Financial Performance - In 2024, the company achieved revenue of 28.396 billion yuan, a year-on-year increase of 0.41%, and a net profit attributable to shareholders of 1.601 billion yuan, up 14.33% year-on-year. The net profit after deducting non-recurring items was 1.600 billion yuan, an increase of 21.79% year-on-year [1][10] - For Q4 2024, the company reported revenue of 6.346 billion yuan, a year-on-year increase of 1.70%, but a quarter-on-quarter decline of 26.60%. The net profit attributable to shareholders was 287 million yuan, down 35.82% year-on-year and 43.63% quarter-on-quarter [1] Product Performance - The production volumes for special chemicals, glyphosate series, fertilizers, and organic silicon series were 530,400 tons, 266,000 tons, 1,353,000 tons, and 270,700 tons respectively, with year-on-year increases of 6.85%, 65.84%, 11.29%, and 38.32%. Sales volumes were 514,100 tons, 244,800 tons, 1,281,300 tons, and 250,100 tons, with year-on-year increases of 14.40%, 42.82%, 3.36%, and 33.53% [3] Market Outlook - The phosphate fertilizer market remains strong, and the demand for new energy battery materials is increasing, which supports the demand for phosphate resources. The company is focusing on increasing its phosphate mining capacity significantly over the next five years [5][9]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company achieved steady growth in annual performance, with a significant cash dividend proposed for shareholders. The 2024 annual report showed revenue of 28.396 billion yuan, a year-on-year increase of 0.41%, and a net profit attributable to shareholders of 1.601 billion yuan, up 14.33% year-on-year. However, Q4 performance was impacted by asset impairment losses of 355 million yuan, leading to a net profit of 287 million yuan, down 35.82% year-on-year and 43.63% quarter-on-quarter. The company plans to distribute a cash dividend of 10 yuan per 10 shares (tax included) and has announced an employee stock ownership plan for 2025 with a fundraising cap of 296.88 million yuan [4][5][6]. Financial Performance Summary - The company reported a revenue of 28.396 billion yuan in 2024, with a year-on-year growth of 0.4%. The net profit attributable to shareholders was 1.601 billion yuan, reflecting a year-on-year increase of 14.3%. The gross margin and net margin for 2024 were 19.5% and 5.6%, respectively, both showing improvements compared to the previous year [7][8]. - The company’s revenue projections for 2025-2027 are 31.161 billion yuan, 32.220 billion yuan, and 33.443 billion yuan, respectively, with net profits expected to be 2.062 billion yuan, 2.327 billion yuan, and 2.682 billion yuan [7][8]. Business Segmentation - In 2024, the company’s revenue from various segments included special chemicals (5.277 billion yuan), fertilizers (4.049 billion yuan), pesticides (5.204 billion yuan), organic silicon (2.647 billion yuan), mining (3.557 billion yuan), and trading logistics (4.226 billion yuan). The year-on-year growth rates for these segments were +4.97%, +12.26%, +21.5%, +23.48%, +100%, and -49.55%, respectively [5][6]. - The profitability of the special chemicals and phosphate mining segments remained strong, while organic silicon and pesticide segments faced profitability challenges [5][6]. Future Outlook - The company is focused on enhancing its industrial chain and accelerating the transition to a world-class fine chemical enterprise. The earnings forecasts for 2025-2027 have been adjusted downward due to ongoing pressures in cyclical businesses like glyphosate and organic silicon [4][5][6].

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - The company reported a revenue of 28.4 billion yuan for 2024, a year-on-year increase of 0.4%, and a net profit attributable to shareholders of 1.6 billion yuan, up 14.3% year-on-year [1][3]. - The company plans to distribute a cash dividend of 10 yuan per 10 shares, totaling 1.1 billion yuan, which accounts for 68.9% of the net profit attributable to shareholders, representing a significant increase of 66.7% year-on-year [3][8]. - The company is a leading player in the phosphate chemical industry, with a complete industrial chain and strong R&D capabilities, currently facing short-term pressure due to product market downturns but is expected to recover as new projects are implemented [8]. Financial Performance - In Q4, the company achieved a revenue of 6.35 billion yuan, a year-on-year increase of 2.7% but a quarter-on-quarter decrease of 26.6%. The net profit attributable to shareholders for Q4 was 290 million yuan, down 35.5% year-on-year and 43.6% quarter-on-quarter [1][3]. - The gross margin for the company was 24.9%, a year-on-year decrease of 2.0 percentage points but an increase of 6.1 percentage points quarter-on-quarter [8]. - The company’s main products, including phosphate rock and glyphosate, showed stable pricing trends, with minor fluctuations in market prices [8]. Product Outlook - The company has a production capacity of 230,000 tons per year for glyphosate and 600,000 tons per year for organosilicon monomers. The current market conditions for these products are at historical lows, but there are signs of potential recovery due to improving demand and reduced competition [8]. - The company is advancing key projects, including a 1 million tons per year optical mining project and a 2 million tons per year phosphate mining project, which are expected to enhance its overall strength [8].